cimetidine has been researched along with Carcinoma, Squamous Cell in 5 studies
Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.
Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The possibility exists that Barrett's esophagus may be acquired in some instances and congenital in others." | 2.36 | Barrett's esophagus. ( Berardi, RS; Devaiah, KA, 1983) |
| "The O/E ratio of oesophageal cancer deaths also fell over the first six years of study, from 5." | 1.28 | Post-cimetidine surveillance for up to ten years: incidence of carcinoma of the stomach and oesophagus. ( Colin-Jones, DG; Langman, MJ; Lawson, DH; Logan, RF; Paterson, KR; Vessey, MP, 1991) |
| "A statistically significant increase in delayed hypersensitivity responses on repeated skin testing during cimetidine hydrochloride therapy was observed." | 1.27 | In vivo anergy reversal with cimetidine in patients with cancer. ( Eisele, D; Richtsmeier, WJ, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berardi, RS | 1 |
| Devaiah, KA | 1 |
| Zeng, P | 1 |
| Xiao, J | 1 |
| Lei, Y | 1 |
| Colin-Jones, DG | 1 |
| Langman, MJ | 1 |
| Lawson, DH | 1 |
| Logan, RF | 1 |
| Paterson, KR | 1 |
| Vessey, MP | 1 |
| Xue, LF | 1 |
| Cheng, J | 1 |
| Wang, JW | 1 |
| Song, Y | 1 |
| Gu, SX | 1 |
| Richtsmeier, WJ | 1 |
| Eisele, D | 1 |
1 review available for cimetidine and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Barrett's esophagus.
Topics: Adenocarcinoma; Adolescent; Adult; Age Factors; Aged; Animals; Barrett Esophagus; Carcinoma, Squamou | 1983 |
1 trial available for cimetidine and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
[Cell-mediated immune function in NPC patients treated with cimetidine].
Topics: Adjuvants, Immunologic; Adult; Carcinoma, Squamous Cell; CD4-CD8 Ratio; Cimetidine; Female; Humans; | 1995 |
3 other studies available for cimetidine and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Post-cimetidine surveillance for up to ten years: incidence of carcinoma of the stomach and oesophagus.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Cimetidine; Cohort Studies; Esoph | 1991 |
[Histamine and lung cancer. II. Human lung cancer cell line and histamine].
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Cell Division; Cell Line; Cimetidine; Histamine; Humans; L | 1988 |
In vivo anergy reversal with cimetidine in patients with cancer.
Topics: Aged; Carcinoma, Squamous Cell; Cimetidine; Head and Neck Neoplasms; Humans; Hypersensitivity, Delay | 1986 |